Decision Diagnostics Corp (DECN)

[1mort]

worth the repost from June 2013 - and still very true:
Small Cap

My final pick is so small you really have to wonder why it’s a public company. Decision Diagonostics (DECN) is a little-known, California-based business whose primary product could rock Johnson & Johnson’s (JNJ) world. According to Forbes, DECN’s Pharma Tech Solutions subsidiary has a test strip product called Genstrip that’s designed specifically for JNJ’s LifeScan Ultra glucose monitoring meters. Over the past decade, JNJ has sold something like $5 billion worth of meters; the test strips are used anywhere from two to eight times per day and selling for $1.25 a pop. DECN, whose own product was approved by the FDA last November, sells for about half the J&J product’s cost, prompting the healthcare giant to sue.

JNJ practically has a monopoly on this market. However,

if DECN is able to successfully get its product into the hands of those who need it,

it will simultaneously save diabetes patients money while

making investors rich.

Currently trading around 24 cents, let me remind you that this is an entirely speculative investment, and because of its low trading volume should only be dealt with using tight stop-losses. Do not consider it for your retirement portfolio.

FULL article:
http://investorplace.com/2013/06/3-ways-to-trade-diabetes-treatment/?cc=msnfeed